Understanding who has the highest risk of rare cancers, including squamous cell esophageal cancer, suggests a potential for targeted screening recommendations.
The tiny, scaffoldlike device facilitates early detection of metastatic cancer cells and improves survival, a new study finds.
A new discovery about a common and potentially deadly bacterium could one day pave the way for new, needed antibiotics.
The marriage of immune science and cancer research may improve survival rates for some individuals with rare cancers. A groundbreaking U-M scientist explains more.
Serotonin may motivate fruit flies to search for protein-rich foods. This, in turn, may explain something about how food affects longevity.
U-M researchers are investigating a new immunotherapy drug for AML in children — one with a built-in "safety switch" in case unexpected adverse reactions occur.